Gabapentin Appears Effective for Menopausal Hot Flushes
Gabapentin may be a beneficial therapeutic option for managing vasomotor symptoms in postmenopausal women.
Diagnosis & Disease Information
Magnesium Inversely Linked to Risk for Coronary Heart Disease
Increase in dietary magnesium associated with reduced risk for fatal CHD in postmenopausal women
Extended Estrogen Therapy Aids Late-Life Cognition
Benefit seen especially in older women and women initiating treatment within five years of menopause
Type and Timing of Menopausal HRT Affect Risk for Breast Cancer
Some excess risk persists for >10 years after ceasing therapy; magnitude varies with duration of use
Vitamin B Intake and Hip Fracture Risk: What’s the Link?
High intake of vitamin B6 and B12 may increase the risk of hip fracture in postmenopausal women, according to the results of a recently published prospective cohort study.
New Drug Product: Bijuva
This slideshow reviews drug information for Bijuva. Click here for the complete Bijuva monograph.
Bijuva Launched for Moderate to Severe Hot Flashes Due to Menopause
TherapeuticsMD announced the launch of Bijuva (estradiol and progesterone) capsules for use in women with a uterus for the treatment of moderate to severe vasomotor symptoms (hot flashes) due to menopause.
Data Submitted to FDA Clarify Interaction Between Addyi and Alcohol
Results from 3 studies evaluating the interaction between Addyi (flibanserin; Sprout), a treatment for hypoactive sexual desire disorder in premenopausal women, and alcohol have been submitted to the FDA for review for inclusion in the product labeling.
Long-Term Systemic Hormone Therapy May Up Alzheimer Risk
Risk increases associated with hormone therapy exposure over 10 years in women <60 years at initiation
Mindfulness, Stress Linked to Menopausal Symptoms
Higher mindfulness and lower stress are independently associated with lower menopausal symptom scores among midlife women.
